{
  "symbol": "AVGR",
  "company_name": "Avinger Inc",
  "ir_website": "https://investors.avinger.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://investors.avinger.com/press-releases",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## Press Releases\n\n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        },
        {
          "title": "Events & Presentations",
          "url": "https://investors.avinger.com/events-presentations",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## Events & Presentations\n\n[Pantheris Device Overview](https://youtu.be/MhCvkqgJRgQ)\n\n[Ocelot Device Overview](https://youtu.be/MhCvkqgJRgQ)\n\n[![Investor Presentation thumbnail](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/Screenshot+2024-10-17+at+4.12.40-PM-1920w.png)](https://irp.cdn-website.com/fd6621ec/files/uploaded/AVGR_Corp_Pres-WS_%28Oct_2024%29.pdf)\n\n[Investor Presentation](https://irp.cdn-website.com/fd6621ec/files/uploaded/AVGR_Corp_Pres-WS_%28Oct_2024%29.pdf)\n\n[![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/Vision-th-1920w.png)](https://irp.cdn-website.com/fd6621ec/files/uploaded/VISION_24_Month_Data_NCVH_.pdf)\n\n[VISION 24-Month Data NCVH Presentation](https://irp.cdn-website.com/fd6621ec/files/uploaded/VISION_24_Month_Data_NCVH_.pdf)\n\n## Upcoming Events\n\n### List of Services\n\n  * [ Avinger Third Quarter 2024 Results Call Date and Time: November 07, 2024 at 4:30 PM ET**View Webcast** Item Link List Item 1 ](https://www.webcaster4.com/Webcast/Page/2212/51496)\n\n\n\n## Past Events\n\n### List of Services\n\n  * [ Avinger Second Quarter 2024 Results Call Date and Time: August 08, 2024 at 4:30 PM ETView Webcast Item Link ](https://www.webcaster4.com/Webcast/Page/2212/50959)\n  * [ Avinger First Quarter 2024 Results Call Date and Time: May 15, 2024 at 4:30 PM ET**View Webcast** Item Link ](https://www.webcaster4.com/Webcast/Page/2212/50594)\n  * [ Avinger Full Year 2023 Results Call Date and Time: March 20, 2024 at 4:30 PM ETJoin the Live Call: 973-528-0011Participant Access Code: 669593**View Webcast** Item Link ](https://www.webcaster4.com/Webcast/Page/2212/49980)\n  * [ Avinger Third Quarter 2023 Results Call Date and Time: October 26, 2023 at 4:30 PM ETJoin the Live Call: 973-528-0011Participant Access Code: 782086**View Webcast** Item Link ](https://www.webcaster4.com/Webcast/Page/2212/49316)\n  * [ Avinger Second Quarter 2023 Results Call Date and Time: July 27, 2023 at 4:30 PM ETJoin the Live Call: 973-528-0011Participant Access Code: 794222**View Webcast** Item Link ](https://www.webcaster4.com/Webcast/Page/2212/48751)\n  * [ Avinger First Quarter 2023 Results Call Date and Time: May 10, 2023 at 4:30 PM ETJoin the Live Call: +1-973-528-0011 Passcode: 969663**View Webcast** Item Link ](https://www.webcaster4.com/Webcast/Page/2212/48274)\n  * [ Avinger Fourth Quarter and Full Year 2022 Results Call Date and Time: March 15, 2023 at 4:30 pm ETJoin the Live Call: +1-973-528-0011 Passcode: 514070**View Webcast** Item Link ](https://www.webcaster4.com/Webcast/Page/2212/47789)\n  * [ Avinger Third Quarter 2022 Results Call Date and Time: November 9, 2022 at 4:30 pm ETJoin the Live Call: +1-973-528-0011 Passcode: 445270 **View Webcast** Item Link ](https://www.webcaster4.com/Webcast/Page/2212/47039)\n  * [ Avinger Second Quarter 2022 Results Call Date and Time: August 11, 2022 at 4:30 PM ETJoin the Live call: +1-203-518-9843Passcode: AVINGER**View Webcast** Item Link List Item 1 ](https://www.webcaster4.com/Webcast/Page/2212/46289)\n  * [ Avinger First Quarter 2022 Results Call Date and Time: May 10, 2022 at 4:30 PM ETJoin the Live call: +1-973-528-0011Passcode: 855404**View Webcast** Item Link List Item 2 ](https://www.webcaster4.com/Webcast/Page/2212/45383)\n  * [ Avinger Fourth Quarter and Full Year 2021 Results Call Date and Time: March 22, 2022 at 4:30 PM ETJoin the Live call: +1-973-528-0016**View Webcast** Item Link List Item 3 ](https://www.webcaster4.com/Webcast/Page/2212/44887)\n  * [ Avinger Third Quarter 2021 Results Call Date and Time: November 11, 2021 at 4:30 PM ET Item Link List Item 4 ]()\n  * [ H.C. Wainwright 23rd Annual Global Investment Conference (Virtual) Avinger will host a group presentation and one-on-one investor meetings with institutional investors. Item Link ]()\n\n\n\n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        },
        {
          "title": "Governance",
          "url": "https://investors.avinger.com/governance",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## Governance\n\n[ Audit Committee ](https://irp.cdn-website.com/fd6621ec/files/uploaded/Avinger_Audit_Committee_Charter.pdf) [ Compensation Committee ](https://irp.cdn-website.com/fd6621ec/files/uploaded/Avinger_Compensation_Committee_Charter.pdf) [ Nominating and Governance Committee ](https://irp.cdn-website.com/fd6621ec/files/uploaded/Avinger_Nominating_and_Corporate_Governance_Committee_Charter.pdf)\n\n[ Code of Business Conduct ](https://irp.cdn-website.com/fd6621ec/files/uploaded/Avinger_Code_of_Business_Conduct.pdf) [ Conflict Minerals Disclosure ](https://irp.cdn-website.com/fd6621ec/files/uploaded/proofs_0001506928_61032_ALL-DOCS_clean_pn2%20%28002%29.pdf) [ Conflict Minerals Policy ](/conflict-minerals-policy) [ California Transparency In Supply Chain Act ](/california-transparency-in-supply-chain-act) [ Form 8937 ](https://irp.cdn-website.com/fd6621ec/files/uploaded/Form%208937%20-%20Avinger%2C%20Inc%20%28Fully-Executed%29.pdf) [ Form 8937 (2018 Consolidation) ](https://irp.cdn-website.com/fd6621ec/files/uploaded/Avinger%2C%20Inc.%20-%20Form%208937%20%282018%20Consolidation%29%20v2%20-%20Fully-Executed.pdf) [ Form 8937 (2019 Consolidation) ](https://irp.cdn-website.com/fd6621ec/files/uploaded/Avinger%2C%20Inc.%20-%20Form%208937%20%282019%20Consolidation%29%20v2%20-%20Fully-Executed.pdf)\n\n## Board of Directors\n\n### List of Services\n\n  * [ James G. Cullen Chairman of the BoardJames G. Cullen has served as a member of our board of directors since December 2014, as our Lead Independent Director since January 2015 and as our Non-Executive Chairman since December 2017. During the last five years, Mr. Cullen has held board and committee positions with various companies. Mr. Cullen is currently a director of Keysight Technologies, which was spun out of Agilent Technologies, where he was previously a director. Mr. Cullen previously served as a director and chairman of the audit committee of Johnson & Johnson and as a director and member of the investment and finance committees of Prudential Financial. From 1993 to 2000, Mr. Cullen was President, Vice Chairman and Chief Operating Officer of Bell Atlantic Corporation (now Verizon). From 1989 to 1993, he was President and Chief Executive Officer of Bell Atlantic-New Jersey. Mr. Cullen holds a B.A. in Economics from Rutgers University and an M.S. in Management Science from the Massachusetts Institute of Technology.\n    * Chair of the Audit Committee\n    * Member of the Compensation Committee\n    * Chair of the Nominating and Governance Committee\nItem Link List Item 1 ](https://www.webcaster4.com/Webcast/Page/2212/46289)\n  * [ Jeffrey M. Soinski Chief Executive Officer & DirectorJeffrey M. Soinski has served as our President, Chief Executive Officer and a member of our Board of Directors since December 2014. From its formation in September 2009 until the acquisition of its Unisyn business by GE Healthcare in May 2013, Mr. Soinski served as Chief Executive Officer of Medical Imaging Holdings and its primary operating company Unisyn Medical Technologies, a national provider of technology-enabled products and services to the medical imaging industry. Mr. Soinski was a Director of Medical Imaging Holdings and its remaining operating company Consensys Imaging Service from September 2009 until its sale in October 2017. Mr. Soinski served periodically as a Special Venture Partner from July 2008 to June 2013 and as a Special Investment Partner since October 2016 for Galen Partners, a leading healthcare-focused private equity firm, which included Medical Imaging Holdings as one of its portfolio companies. From 2001 until its acquisition by C.R. Bard in 2008, Mr. Soinski was President and CEO of Specialized Health Products International, a publicly-traded manufacturer and marketer of proprietary safety medical products. He served on the board of directors of Merriman Holdings, parent of Merriman Capital, a San Francisco-based investment banking and brokerage firm, from 2008 until March 2016. Mr. Soinski holds a B.A. degree from Dartmouth College. Item Link ]()\n  * [ James B. McElwee DirectorJames B. McElwee has served as a member of our board of directors since March 2011. Mr. McElwee served as general partner of Weston Presidio, a private equity and venture capital firm, from 1992 to 2010. During his tenure as a general partner and member of the investment committee, Weston Presidio led the start up financing of JetBlue Airways and made investments in Fender Musical Instruments, The Coffee Connection, Guitar Center, Mapquest, Party City, Petzazz, RE/ MAX, and others. Prior to Weston Presidio, Mr. McElwee was Senior Vice President of the Security Pacific Venture Capital Group and the founding Managing Director of its Menlo Park office where he was responsible for early private investments in Costco, Universal Health Services, Cypress Semiconductor, Aspect Telecommunications, Xilinx, MIPS Computer Systems, Harmonic, Microchip, Vitesse and others. Prior to entering the venture capital industry in 1979, Mr. McElwee was a Senior Consultant with Accenture working on a variety of clients in the retailing, healthcare and technology industries. Mr. McElwee holds a B.A. in Economics from Claremont McKenna College and an M.B.A. from the Wharton Graduation School of Business.\n    * Member of the Audit Committee\n    * Chair of the Compensation Committee\n    * Member of the Nominating and Governance Committee\nItem Link ]()\n  * [ Tamara Elias DirectorTamara N. Elias, M.D., was appointed to our board of directors in December 2019. Dr. Elias currently serves as VP, Head of Global Partnerships at Merck. Previously she served as Vice President of Clinical Product Development at Aetna from February 2018 to December 2019. From 2015 to 2017, Dr. Elias was Vice President of Corporate Strategy and Business Development for the $8 billion medical segment at Becton Dickinson. From 2007-2015, Dr. Elias was a Partner with Essex Woodlands Healthcare Partners, a healthcare only growth equity firm founded in 1985. Earlier in her career, Dr. Elias was a management consultant at McKinsey, advising pharmaceutical, diagnostic and device companies in R&D, product commercialization and M&A. She currently serves on the board of REVA Medical and has also previously served on the boards of several private companies, including Millennium Pharmacy Systems (sold to PharMerica), BreatheAmerica and Influence Health (sold to Healthgrades) as well on the public company board of ATS Medical (sold to Medtronic). Dr. Elias holds degrees in Biology and Anthropology from Yale University, and an M.D. from The Johns Hopkins School of Medicine. She trained as a general surgeon at Massachusetts General Hospital.\n    * Member of the Audit Committee\n    * Member of the Compensation Committee\n    * Chair of the Nominating and Governance Committee\nItem Link ]()\n\n\n\n## Executive Officers\n\n### List of Services\n\n  * [ Jeffrey M. Soinski Chief Executive Officer & DirectorJeff Soinski has served as our President, Chief Executive Officer and a member of our Board of Directors since December 2014. From its formation in September 2009 until the acquisition of its Unisyn business by GE Healthcare in May 2013, Mr. Soinski served as Chief Executive Officer of Medical Imaging Holdings and its primary operating company Unisyn Medical Technologies, a national provider of technology-enabled products and services to the medical imaging industry. He remained a director of Medical Imaging Holdings and its remaining operating company Consensys Imaging Service until its acquisition in October 2017. Mr. Soinski served periodically as a Special Venture Partner from July 2008 to June 2013 and as a Special Investment Partner since October 2016 for Galen Partners, a leading healthcare-focused private equity firm. From 2001 until its acquisition by C.R. Bard in 2008, Mr. Soinski was President and CEO of Specialized Health Products International, a publicly-traded manufacturer and marketer of proprietary safety medical products. Earlier in his career, Mr. Soinski was President and CEO of ViroTex Corporation, a venture-backed pharmaceutical drug delivery company he sold to Atrix Laboratories in 1998. Mr. Soinski served on the board of directors of Merriman Holdings, parent of Merriman Capital, a San Francisco-based investment banking and brokerage firm, from 2008 until March 2016. He holds a B.A. degree from Dartmouth College. Item Link ]()\n  * [ Himanshu N. Patel Chief Technology OfficerHimanshu Patel has served as Chief Technology Officer of Avinger since its founding in 2007. Mr. Patel brings over 25 years of design experience developing medical devices, primarily for cardiovascular and peripheral artery disease treatment. He has extensive experience leading R&D and manufacturing operations across several companies and has served as a named inventor in more than 25 medical device patents. Mr. Patel founded Avinger in 2007, leading the company in the rapid development of new products that address specific unmet clinical needs in the treatment of peripheral artery disease. He spearheaded engineering efforts of the current platform of image-guided (“Lumivascular”) interventional devices at Avinger, and has played a central role in the development of products that have generated over $1 billion in shareholder value over the course of his career. Prior to Avinger, Mr. Patel led R&D activities as the Director of Advanced Technologies at FoxHollow, and spearheaded the engineering efforts of a $180 million revenue product. His other experience includes designing and developing shape memory alloy stents and multi-component stent-graft devices at EndoTex Interventional Systems, and improving the manufacturing processes of medical devices at General Surgical Innovations, amongst others. Mr. Patel has a proven track record of developing products that exceed customer expectations, with a focus on cost containment, speed to market, and manufacturability. Mr. Patel holds a B.S. in Mechanical Engineering from M.S. University of Baroda, India, and an M.S. in Mechanical Engineering from the University of Florida. Item Link List Item 1 ](https://www.webcaster4.com/Webcast/Page/2212/46289)\n\n\n\n## Compensation Committee\n\nBelow is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.\n\nAudit Committee | Compensation Committee | Nominating and Governance Committee  \n---|---|---  \nJames B. McElwee | Member | Chairperson | Member  \nJames G. Cullen | Chairperson | Member | Chairperson  \nTamara Elias | Member | Member | Chairperson  \n  \n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        },
        {
          "title": "Stock Info",
          "url": "https://investors.avinger.com/stock-info",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## Stock Info\n\n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        },
        {
          "title": "Analyst Coverage",
          "url": "https://investors.avinger.com/analyst-coverage",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## Analyst Coverage\n\nSwayampakula Ramakanth, Ph.D. (RK)\n\nManaging Director, Equity Research \n\nH.C. Wainwright & Co., LLC\n\n430 Park Avenue\n\nNew York, NY 10022\n\n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        },
        {
          "title": "Financials",
          "url": "https://investors.avinger.com/financials",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## SEC Filings\n\n[Download Form 8937 >](https://irp.cdn-website.com/fd6621ec/files/uploaded/Form 8937.pdf)\n\n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        },
        {
          "title": "FAQs",
          "url": "https://investors.avinger.com/faqs",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## FAQs\n\n  * ### What does Avinger do?\n\nAvinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease, or PAD. The company manufactures and sells a suite of products including the Lightbox imaging console, as well as the Wildcat, Kittycat, and the Ocelot family of catheters. Avinger is based in Redwood City, California.\n\n  * ### On what stock exchange are Avinger shares traded, and what is the ticker symbol?\n\nThe Avinger ticker is AVGR and it is traded on The Nasdaq Capital Market.\n\n  * ### When was Avinger’s Initial Public Offering?\n\nJanuary 30, 2015.\n\n  * ### Where can I find all of Avinger’s SEC filings? Where can I download and view quarterly and annual reports?\n\nQuarterly and annual reports, as well as other SEC filings, can be accessed on the Financials portion of our Investor Relations website or directly from the SEC at www.sec.gov.\n\n  * ### When does Avinger’s fiscal year end?\n\n31 December\n\n  * ### Does Avinger pay dividends?\n\nAvinger does not expect to declare or pay any cash or other dividends on our common stock.\n\n  * ### Who are the company's independent registered public accountants?\n\nMoss Adams LLP\n\n  * ### Who is the company's transfer agent?\n\nAvinger’s transfer agent is Entiquiti Trust Company LLC. You can reach them at 1-800-937-5449 or via email at HelpAST@equiniti.com.\n\n  * ### Who is the company's outside legal counsel?\n\nDorsey & Whitney LLP\n\n  * ### Who are the members of Avinger’s Board of Directors?\n\nYou can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.\n\n  * ### Who are the members of the Avinger’s Executive management team?\n\nYou can view our Executive management team by visiting the Management section of our Investor Relations website. You can also view our extended Management at https://avinger.com/about-avinger/.\n\n  * ### When is your next earnings release?\n\nAvinger will issue a press release that includes the date of our quarterly earnings call. When the release is issued, it will be posted on the “Events” section of our website along with the details for a conference and/or webcast to discuss the results.\n\n  * ### How do I contact Investor Relations with a question or request?\n\nYou can contact Avinger Investor Relations through Matt Kreps at Darrow Associates, mkreps@darrowir.com or +1-214-597-8200.\n\n  * ### Where and when was Avinger incorporated?\n\nAvinger, Inc. was incorporated in Delaware in March of 2007.\n\n  * ### How can I update my stockholder information for an address or name change? Can I replace a lost certificate?\n\nIf your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, address changes should be submitted in writing by U.S. Mail to our transfer agent: American Stock Transfer & Trust Company, LLC. You can reach them at 1-800-937-5449 or via email at help@astfinancial.com.\n\n  * ### Where can I find form 8937 for Avinger?\n\nPlease [download the file here](https://irp.cdn-website.com/fd6621ec/files/uploaded/Form 8937.pdf).\n\n\n\n\n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        },
        {
          "title": "Investor Alerts",
          "url": "https://investors.avinger.com/investor-alerts",
          "content": "[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n[![](https://irp.cdn-website.com/fd6621ec/dms3rep/multi/logo.svg)](https://avinger.com/)\n\n# INVESTORRELATIONS\n\n## Investor Alerts\n\nYou may automatically receive Avinger Inc news and updates by email. Choose your options for email notification, please enter your email address below and click Submit. Required fields denoted by an asterisk ( *).\n\nPress Releases\n\nEmail *\n\n[LUMIVASCULAR](https://avinger.com/lumivascular/)\n\n[Radiation-Free](https://avinger.com/lumivascular/radiation/)\n\n[Technology](https://avinger.com/lumivascular/radiation/)\n\n[PRODUCTS](https://avinger.com/devices/)\n\n[Lightbox](https://avinger.com/devices/lightbox/)\n\n[Ocelot](https://avinger.com/devices/ocelot/)\n\n[TigerEye](https://avinger.com/devices/tigereye/)\n\n[Pantheris](https://avinger.com/devices/pantheris/)\n\n[HEALTHCARE](https://avinger.com/physicians/)\n\n[PROFESSIONALS](https://avinger.com/physicians/)\n\n[Case Studies](https://avinger.com/physicians/case-studies/)\n\n[Publications](https://pages.avinger.com/peripheral-arterial-disease-publications-index)\n\n[Site Map](https://pages.avinger.com/sitemap)\n\n[PATIENTS](https://avinger.com/patients/)\n\n[Patient Stories](https://avinger.com/patients/patient-stories/)\n\n[Blog](http://blog.avinger.com/blog)\n\n[INVESTORS](/)\n\nABOUT AVINGER\n\n[Careers](https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=9397dfb6-f287-4ad9-a591-f2335e5d1e94&ccId=19000101_000001&lang=en_US)\n\n[Contact](http://avinger.com/about-avinger/#contact-link)\n\n[Investors](https://avinger.com/about-avinger/investors/)\n\n[ Find a Doctor ](https://pages.avinger.com/find-a-doctor)\n\n[ ](https://www.facebook.com/Avinger.Inc) [ ](https://twitter.com/avingerinc) [ ](http://www.linkedin.com/company/1049258?trk=vsrp_companies_res_name&trkInfo=VSRPsearchId%3A1283030111480541533442%2CVSRPtargetId%3A1049258%2CVSRPcmpt%3Aprimary) [ ](https://www.youtube.com/channel/UC8FKDHdEPUtXxWKH6zSbbVA)\n\n![](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/logo-beyond-1920w.png)\n\n© 2024 \n\nAvinger. All Rights Reserved\n\n[Terms of Use](https://avinger.com/terms-of-use/)|[Policies](https://avinger.com/policies/)|[Patents](https://avinger.com/patents/)\n\n![US Flag](https://lirp.cdn-website.com/fd6621ec/dms3rep/multi/opt/flag-us-1920w.png)\n\nUnited States\n\nShare by:\n"
        }
      ]
    }
  ]
}